about
The hyalectan degrading ADAMTS-1 enzyme is expressed by osteoblasts and up-regulated at regions of new bone formationExcessive dietary intake of vitamin A reduces skull bone thickness in mice.Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANKOlfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.Vitamin a is a negative regulator of osteoblast mineralization.Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts.Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site.Microarray profiling of diaphyseal bone of rats suffering from hypervitaminosis A.Purification of an insect derived recombinant human ADAMTS-1 reveals novel gelatin (type I collagen) degrading activities.Studies of indirect and direct effects of hypervitaminosis A on rat bone by comparing free access to food and pair-feedingBones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy overexpressionADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processingPurification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesisAccessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumoursBiosynthesis of heparin/heparan sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyltransferase reactions
P50
Q28564839-FB39C55C-648A-48AD-97AF-81C092B4E095Q33585182-2C7054A1-4533-4D1F-AE9E-12410EE8CE12Q33719241-EDDC1C18-BAA3-4059-9799-F8619AD200C2Q34489448-19087C6D-AF17-4A3E-A8CF-CF8DAA25C6D2Q35067782-2CE5DCA9-1FFA-4C84-A499-67ABB05AC2BFQ36152650-0ADE9ECC-561F-486B-94CF-2733605CA62AQ36218356-675DED56-A0EA-4B74-A04C-F4A4AAEDFC59Q38336699-1E482727-BE9B-4557-8BC1-31991D9A61EFQ38499043-4B991BFF-28FC-4C8D-A407-C69E3DDC5170Q40343538-EA605169-4C7B-4770-9875-BFD11AAF6D79Q58831336-15D95078-EB67-4302-B11C-3A383822B925Q58831338-057BA871-895F-4B33-9E39-73043E6BE247Q58831347-D237171D-E74D-475C-8655-B09CA7A168CCQ58831352-B3F5158D-7509-47A7-88DC-0C3266B1E454Q58831356-CA47078E-CC23-4BC2-A31F-99C95507AF2BQ58831360-3AC3F1D6-37E0-4DED-91A7-15A23045A1ED
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Lind
@ast
Thomas Lind
@en
Thomas Lind
@es
Thomas Lind
@nl
type
label
Thomas Lind
@ast
Thomas Lind
@en
Thomas Lind
@es
Thomas Lind
@nl
prefLabel
Thomas Lind
@ast
Thomas Lind
@en
Thomas Lind
@es
Thomas Lind
@nl
P106
P1153
57189656551
P31
P496
0000-0003-2791-688X